APA (7th ed.) Citation

Falcone, M., Canducci, F., Saita, D., Ferrarese, R., Cosorich, I., Di Pietro, C., . . . Clementi, M. (2016). Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment. Journal of Diabetes Research, 2016(2016), 1-12. https://doi.org/10.1155/2016/7569431

Chicago Style (17th ed.) Citation

Falcone, Marika, Filippo Canducci, Diego Saita, Roberto Ferrarese, Ilaria Cosorich, Caterina Di Pietro, Chiara Sorini, Jayashree Dolpady, and Massimo Clementi. "Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment." Journal of Diabetes Research 2016, no. 2016 (2016): 1-12. https://doi.org/10.1155/2016/7569431.

MLA (9th ed.) Citation

Falcone, Marika, et al. "Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment." Journal of Diabetes Research, vol. 2016, no. 2016, 2016, pp. 1-12, https://doi.org/10.1155/2016/7569431.